RMC No. 5-2022: FDA-Endorsed Updates to VAT-Exempt Products List for Medicines and Health Items

RMC No. 5-2022 republishes the FDA-endorsed updates to VAT-exempt products, affecting businesses handling medicines for kidney diseases. Immediate compliance is required. Businesses handling medicines for kidney diseases and related health products must update their VAT exemption practices immediately. RMC No. 5-2022 republishes the Food and Drug Administration’s letter endorsing updates to the list of VAT-exempt […]